START-UP PACKAGE

Gareth, founder of Pacifi, maintains extensive experience in New Business Development and Key Account Management, focusing on the strategic Development & Manufacture of Primary Pharmaceutical Packaging and Medical Devices. 

Kevin is a co-founder and Venture Partner at Medicxi. Prior to Medicxi, Kevin was a Partner at Index Ventures for 13 years, having joined in 2003.  Kevin originated Index’s first asset-centric investment in PanGenetics (acquired by Abbott) and led Medicxi’s investment in Impact Biomedicines (acquired by Celgene). Kevin currently serves on the board of Levicept. 
Prior to joining Index, Kevin was with Cambridge Antibody Technology (CAT) where he was appointed Head of Research in 1994 and then Research Director and Chief Technology Officer in 1997. Kevin led the development of CAT's platform technologies and oversaw their application in the discovery of a number of human antibodies - two of which are now marketed worldwide: Humira (by Abbott Pharmaceuticals) and Benlysta (by GlaxoSmithKline). Kevin was part of the management team that floated CAT on the London Stock Exchange (subsequently acquired by AstraZeneca). 
Kevin received a BSc in Molecular Biology from Edinburgh University and a PhD in Pathology from Cambridge University. He also acts as chairman of Crescendo Biologics. 

Matt is an M&A transaction specialist with 14 years’ experience including 4 years in Deloitte’s transactions and restructuring team, 3 years executing highly structured deals at Barclays Capital, and 4 years originating and executing deals at boutique M&A advisory Corbett Keeling.  

Marc Chevalier holds a PhD in Neuroscience. He is strongly involved in building bridges between PhDs and ecosystems outside academia in order to increase the opportunities for PhDs to succeed in their careers. He has been Career Advisor at the Institut Pasteur and Responsible for Entrepreneurship and Startup Creation in the Institut Pasteur and the Imagine Institute of Genetic Disease prior becoming Director of Innovation of the Lyric Institute. He is now entrepreneur (CEO of NeckEpur) and he is continuing guiding scientists and professionals in the transition from Research to Development & Innovation (RDI), startup creation & developing their entrepreneurial mindset as well as the development of their career.

Thomas is a successful life science corporate finance advisor, capital sourcing expert, investor and mentor. With his large network and long-standing experience in working with Life Sciences companies he’s a trusted partner to his clients. Building bridges between company owners and investors, constructing compelling equity stories, deal moderation and negotiation are his speciality.

Holding a M.Eng, M.Sc and an MBA, Vincent is a healthcare consultant and entrepreneur with 10 years of experiences in digital health and international relations. Founder of Digital Pharma Lab, the first independant pharmatech accelerator in Europe and Coalition Next, the first public-private health innovation coalition in France. He is driven by being at the intersection of technology and life sciences to serve the unmet needs of patients, caregivers and physicians. International experience in the U.S. and multiple European countries across startups operations management, strategy consulting, government diplomacy and entrepreneurship.